Clinical trial
A Study of a Monoclonal Antibody, KW-2871, in Patients With Advanced Melanoma
NCT00199342 · Kyowa Kirin, Inc., Industry · Terminated
Key facts
| NCT number | NCT00199342 |
|---|---|
| Title | A Study of a Monoclonal Antibody, KW-2871, in Patients With Advanced Melanoma |
| Official title | An Open-Label Study of KW-2871 Administered With a Premedication Regimen in Patients With Advanced Stage IV Melanoma |
| Lead sponsor | Kyowa Kirin, Inc., Industry |
| Status | Terminated |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Stage IV Melanoma |
| Intervention type | Drug |
| Interventions | KW-2871 |
| Enrollment | 5 |
| Start date | Nov 1, 2004 |
| Primary completion | Oct 1, 2005 |
| First posted | Sep 20, 2005 |
| Last update posted | May 3, 2024 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: